
Massive Bio bridges the gap between top-tier oncology expertise and community practices by offering personalized cancer treatment options through targeted therapies and genomics. The company's platform facilitates virtual tumor boards, enabling treating oncologists to leverage expert recommendations without additional time or cost. This approach ensures that all patients have equal access to cutting-edge research and treatments, addressing the challenges faced by overwhelmed community practices.
Massive Bio is a rapidly growing health-tech startup focused on providing access to cancer clinical trials, particularly in France. They are seeking a Key Account Manager (KAM) to drive institutional adoption of their platform by engaging referring hospitals and IT teams. The role involves identifying, prioritizing, and closing partnerships to launch clinical trial engagement programs.
Massive Bio bridges the gap between top-tier oncology expertise and community practices by offering personalized cancer treatment options through targeted therapies and genomics. The company's platform facilitates virtual tumor boards, enabling treating oncologists to leverage expert recommendations without additional time or cost. This approach ensures that all patients have equal access to cutting-edge research and treatments, addressing the challenges faced by overwhelmed community practices.